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Abstract In multiple sclerosis (MS), and its animal
model experimental autoimmune encephalomyelitis
(EAE), dysfunction of the blood–brain barrier (BBB) leads
to edema formation within the central nervous system. The
molecular mechanisms of edema formation in EAE/MS are
poorly understood. We hypothesized that edema formation
is due to imbalanced water transport across the BBB
caused by a disturbed crosstalk between BBB endothelium
and astrocytes. Here, we demonstrate at the light micro-
scopic and ultrastructural level, the loss of polarized
localization of the water channel protein aquaporin-4
(AQP4) in astrocytic endfeet surrounding microvessels
during EAE. AQP4 was found to be redistributed over the
entire astrocytic cell surface and lost its arrangement in
orthogonal arrays of intramembranous particles as seen in
the freeze-fracture replica. In addition, immunostaining for
the astrocytic extracellular matrix receptor b-dystroglycan
disappeared from astroglial membranes in the vicinity of
inflammatory cuffs, whereas immunostaining for the dys-
troglycan ligands agrin and laminin in the perivascular
basement membrane remained unchanged. Our data sug-
gest that during EAE, loss of b-dystroglycan-mediated
astrocyte foot process anchoring to the basement
membrane leads to loss of polarized AQP4 localization in
astrocytic endfeet, and thus to edema formation in EAE.
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Introduction
Homeostasis of the central nervous system (CNS) micro-
environment is essential for its normal function and is
maintained by the blood–brain barrier (BBB). During
pathological conditions of the CNS such as in multiple
sclerosis (MS), or in its animal model experimental auto-
immune encephalomyelitis (EAE), loss of barrier
properties of the highly specialized cerebral endothelium
leads to edema formation and exacerbation of clinical
disease [24, 30]. The BBB is formed by highly specialized
endothelial cells, which inhibit transcellular passage of
molecules across the barrier by an extremely low pinocy-
totic activity and restrict the paracellular diffusion of
hydrophilic molecules due to an elaborate network of
complex tight junctions (TJ) between the endothelial cells
(as reviewed in [9, 37]). While the endothelial cells form
the barrier proper, integrity of the BBB critically depends
on the continuous crosstalk between the cellular elements
within the neurovascular unit. Pericytes embedded into the
endothelial basement membrane, are required for the
maturation of the BBB [12]. In addition, astrocytes closely
embrace CNS microvessels covering almost entirely the
abluminal vascular surface with their endfeet. Astrocytes
deposit a second basal lamina around CNS microvessels,
referred to as glial basal lamina or glial limiting membrane.
The endothelial and the glial basement membranes differ in
their laminin composition with laminins 411 and 511 in the
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endothelial basal lamina, versus laminins 111 and 211
deposited in the glial limiting membrane [1, 29].
In EAE, inflammatory cells therefore have to breach the
endothelial barrier and both basal laminae before reaching
the CNS parenchyma proper. Activity of matrix metallo-
proteinases MMP2 and MMP9 is required for leukocyte
migration across the astroglial basal lamina but dispensable
for leukocyte entry across the endothelial BBB and the
endothelial basal lamina [1]. MMP2 and MMP9 cleave the
extracellular matrix receptor b-dystroglycan localized in
the astrocytic endfoot membrane during their passage into
the CNS. Besides laminin, b-dystroglycan binds agrin, a
heparan sulfate proteoglycan localized in the basal laminae
of the CNS microvessels and proposed to be involved in
the development of the BBB [4]. Linkage of astrocytic foot
processes to agrin via b-dystroglycan may therefore be
critical for correct astrocyte anchoring in the neurovascular
unit (NVU).
Freeze-fracture electron microscopy has revealed
astrocyte polarity within the NVU by revealing structural
heterogeneity of specific membrane domains on the as-
troglial surface. Membranes of astrocyte endfeet, but not
parenchymal membranes of the astrocyte, are studded with
numerous orthogonal arrays of intramembranous particles
(OAPs) (as summarized in [36]). The molecular entity
found in OAPs is the water channel protein aquaporin-4
(AQP4) [22, 23], suggesting that in EAE loss of astrocyte
polarity may lead to loss of directed water transport across
astrocytes causing vascular or cytotoxic edema.
In the past, an altered expression of AQP4 in inflam-
matory diseases of the brain has been described. Aoki-
Yoshida et al. [3] and Sinclair et al. [28] found an enhanced
expression of AQP4 in human multiple sclerosis. In con-
trast, in the autoimmune disorder neuromyelitis optica
(NMO), in which the autoantigen is AQP4 [10], AQP4 was
found to be absent [28].
In this study, we have investigated the distribution of
AQP4 in EAE plaques and demonstrate that in fact edema
formation in EAE is accompanied by the loss of polarized
localization of AQP4 and the K? channel Kir4.1 on
astrocytic foot processes within the NVU. Freeze-fracture
analysis confirmed the loss of astrocyte polarity by dem-
onstrating a rearranged architecture of parenchymal
membrane domains of astrocytes adjacent to inflammatory
cuffs. Failure to maintain cell polarity seemed to be caused
by the cleavage of the extracellular matrix receptor b-
dystroglycan at the astrocytic foot process leading to the
loss of contact with the basement membrane ligands lam-
inin and agrin, presence of which remains unchanged
within the glial limiting membrane. Our data suggest that
during EAE the distribution of AQP4 and OAPs in the
astrocyte membrane has been changed. It is tempting to
speculate that these changes are linked to the loss of
b-dystroglycan, leading to a reduction of astrocyte polari-
zation, and thus to edema formation in EAE.
Materials and methods
Animals and induction of EAE
Female SJL/N mice were obtained from Harlan (The
Netherlands) and used for experiments at the age of
10 weeks. Active EAE (aEAE) was induced by immu-
nization with PLP-peptide as described in detail before
[32]. Animals were checked daily and clinical severity
(clinical score) was documented as follows: Ø without
symptoms; 0.5 = limp tail; 1 = weak hind limbs;
2 = paraplegic; 3 = paraplegic, incontinent and weak-
ness. Animal experiments were performed in accordance
to the Swiss legislation with permission of the local
authorities.
Antibodies
The following antibodies were used to detect specific water
channel and tight junction proteins: polyclonal rabbit anti-
aquaporin-4 antiserum (Chemicon, Hofheim, Germany),
polyclonal rabbit anti-claudin-3 (Zymed, Invitrogen,
Karlsruhe, Germany), polyclonal rabbit anti-claudin-5 [11],
polyclonal rabbit anti-occludin (Zymed, Invitrogen,
Karlsruhe, Germany), polyclonal rabbit anti-GFAP (1:500;
DAKO, Hamburg, Germany), polyclonal rabbit anti-ZO-1
and monoclonal mouse anti-ZO-1 (Zymed, Invitrogen,
Karlsruhe, Germany), polyclonal rabbit anti-Kir4.1
(Alomone Labs, Jerusalem, Israel), sheep anti-human
fibronectin, FITC-conjugated (1:100; BioTrend, Cologne,
Germany), monoclonal mouse anti-b-dystroglycan (Novo-
Castra, Newcastle, UK), polyclonal rabbit anti-agrin
(provided by Dr. S. Kröger), polyclonal rabbit anti-laminin
(DAKO, Hamburg, Germany), monoclonal anti-rat CD45
(BD Pharmingen). If not otherwise mentioned, all antisera
were used in a dilution of 1:100.
The secondary goat-anti-mouse, or goat-anti-rabbit
antibodies labeled with cyanin-derivative dye Cy2, Cy3 or
Cy5 were purchased from Dianova (Hamburg, Germany).
For controls, the primary antibody was omitted.
Gel electrophoresis and western blot
Mice with EAE and healthy controls were anesthetized
and perfused with cold phosphate buffered saline (PBS).
The cerebellum was removed and homogenized in 10
volumes (w/v) of ice-cold RIPA buffer (50 mM Tris pH
7.5, 150 mM NaCl, 0.5% Nadeoxycholate, 0.1% SDS, 1%
NP-40) containing protease inhibitors (Complete Mini
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EDTA-free protease inhibitor cocktail tablets, Roche).
After a 5 min centrifugation step at 3,0009g the super-
natant was harvested and the protein concentration was
determined with the BCA protein assay kit (Pierce). The
samples were mixed with 29 sample buffer (Laemmli
Buffer, 200 mM DTT), 90 lg of proteins per sample
separated on a 10% polyacrylamide gel and blotted on
nitrocellulose (Whatman Protran transfer membrane,
0.2 mM pore size). After blocking the membrane in PBS
containing 2% (w/v) BSA (Albumin fraction V, Appli-
chem) for 20 min at RT, the membrane was incubated
overnight with the mouse monoclonal anti b-actin anti-
body (A5316, Sigma) diluted 1:1,000 in PBS/2% BSA at
4C. After washing with PBS, the primary antibody was
detected by goat-anti-mouse IRDye 680 (LI-COR Bio-
sciences). The rabbit polyclonal anti-AQP4 antibody
(AB2218, Millipore) was diluted 1:500 in PBS/2% BSA
and the membrane was incubated for 1 h at RT. The
primary antibody was revealed with goat-anti-rabbit IR-
Dye 800CW (LI-COR Biosciences) and the membrane
was scanned with the Odyssey Infrared imaging system.
The integrated intensity of the bands was determined
using Odyssey 2.1 software. The AQP4 bands were nor-
malized to the corresponding b-actin bands for each
individual sample.
Immunohistochemistry
Mice with EAE or healthy littermates were killed, and
their brains were removed, embedded in Tissue Tek
(OCT; Miles, Vogel, Giessen, Germany) and snap-frozen
in a 2-methylbutane (Merck, Darmstadt, Germany) bath
at -80C. Cryostat sections (8–12 lm thick) were cut
using a Reichert-Jung Frigocut 2800 E cryotome (Reic-
hert, Vienna, Austria), mounted on glass slides coated
with poly-L-lysine (Sigma), and air dried. To avoid
unspecific staining, the sections were blocked by incu-
bation with 5% (w/v) skimmed milk, 0.3% (w/v) Triton
X-100 (Serva, Heidelberg, Germany) and 0.4% (w/v)
NaN3 in TBS for 30 min. Primary antibodies diluted in
the same solution were applied overnight at 4C. After
three washes in TBS for 10 min, sections were incubated
for 45 min with the secondary antibody at room tem-
perature. Following washes in TBS, sections were
mounted in Mowiol. Sections were analyzed with a
confocal laser scanning microscope (LSM510 META
with an Axioplan 2 microscope stand, Zeiss, Göttingen/
Jena, Germany) using lasers at 488, 546, and 633 nm for
excitation with appropriate filter sets. The system’s multi-
track function was used to generate images for each stain
and excitation sequentially. Images were processed using
Adobe Photoshop (version 7.0, Adobe, Mountain View,
USA).
Immunogold labeling
Post-embedding immunogold labeling was performed on
ultrathin sections of Lowicryl-embedded specimens. The
tissues were fixed with 3% paraformaldehyde plus 0.1%
glutaraldehyde in phosphate buffer pH 7.2 for 4 h, then
dehydrated and embedded in Lowicryl K4M at low tem-
perature in a Balzers low temperature embedding apparatus
(LTE 020; Balzers, Liechtenstein), followed by UV poly-
merization at low temperature in a Balzers freezer (TTP
010; Balzers, Liechtenstein). The sections were cut on a
Leica Ultracut R at 50–70 nm and mounted on Pioloform-
coated nickel grids (SCI, Munich, Germany). For on-sec-
tion labeling, grids were floated on drops of the following
solutions and transferred using a nickel-coated copper loop.
Initially, the grids were floated for 5 min on TBS followed
by blocking buffer [5% (w/v) bovine serum albumin, 0.1%
(v/v) cold water fish skin gelatin (Biotrend), 5% (v/v)
normal goat serum (Biotrend), and 0.04% NaN3 in TBS]
for 30 min to minimize unspecific binding. The primary
antibody was diluted (1:20 or 1:50) in incubation buffer
[0.8% (w/v) bovine serum albumin, 0.1% (v/v) cold water
fish skin gelatine, and 0.04% NaN3 in TBS], and the sec-
tions were incubated overnight at 4C. The sections were
washed several times in incubation buffer and subsequently
incubated for 1 h with gold-conjugated secondary anti-
bodies (British Biocell Int., Cardiff, UK) diluted 1:50 in
incubation buffer. Following several washes in the same
buffer and in TBS, the sections were postfixed with 2%
glutaraldehyde and finally washed in double-distilled
water. The sections were contrasted with 8% watery uranyl
acetate. The specimens were observed and documented
with a Zeiss EM10A electron microscope (Zeiss, Oberko-
chen, Germany).
Conventional electron microscopy of vibratome
sections
Mice were transcardially perfused with 2.5% glutaralde-
hyde (Paesel-Lorei, Frankfurt, Germany) buffered in 0.1 M
cacodylate buffer (pH 7.4). Thereafter, the cerebellar and
spinal cord tissue was dissected out and postfixed in the
identical fixative for additional 4 h, and then stored in
cacodylate until further processed. The tissues were sec-
tioned with an Oxford Vibratome (Oxford, UK) into 50-
lm-thick sections, which were consecutively used for
embedding and freeze-fracturing (see there). For embed-
ding, the vibratome sections (1, 3, 5, …) were postfixed in
1% OsO4 in 0.1 M cacodylate buffer and then dehydrated
in an ethanol series (50, 70, 96, 100%). The 70% ethanol
was saturated with uranyl acetate for contrast enhancement.
Dehydration was completed in propylene oxide. The
specimens were embedded in Araldite (Serva, Heidelberg,
Acta Neuropathol (2009) 118:219–233 221
123
Germany). Semi- and ultra-thin sections were produced on
a FCR Reichert Ultracut ultramicrotome (Leica, Bensheim,
Germany). The semi-thin sections were used for inspection
of inflammatory cuffs. If they were present, conventional
electron microcopy was made from this site, and the
ultrathin sections were mounted on Pioloform-coated
copper grids, contrasted with lead citrate and analyzed and
documented with an EM10A electron microscope (Carl Zeiss,
Oberkochen, Germany). In this case, the next vibratome sec-
tions (2, 4, 6, …) were used for freeze-fracturing transmission
electron microscopy.
Freeze-fracturing
The vibratome sections produced as described above were
cryoprotected for freeze-fracturing in 30% glycerol and
quick-frozen in nitrogen-slush (-210C). Subsequently, the
specimens were fractured in a Balzer’s freeze-fracture device
(BAF400D; Balzers, Liechtenstein) at 5 9 10-6 mbar and
-150C. The fracture faces were shadowed with platinum/
carbon (2 nm, 45) for contrast and carbon (20 nm, 90) for
stabilization of the replica. After removing the cell material in
12% sodium hypochlorite, the replicas were cleaned several
times in double-distilled water and mounted on Pioloform-
coated copper grids. The replicas were observed using an
EM10A electron microscope (Carl Zeiss, Oberkochen,
Germany).
Results
In this study, we investigated inflammatory cuffs in the
cerebellum and the spinal cord of mice with different
clinical severity of EAE by means of both confocal laser
scanning immunohistochemistry and immunogold labeling
as well as by means of freeze-fracturing. We used anti-
bodies against CD45 in order to identify inflammatory
cells, against endothelial tight junctions (ZO-1, occludin,
claudin-3 and claudin-5) in order to test the conditions of
the BBB in the postcapillary venules, and against astroglial
antigens such as the water channel protein aquaporin-4
(AQP4), the K? channel Kir4.1, glial fibrillary acidic
protein (GFAP), and the dystrophin–dystroglycan complex
(DDC) (b-dystroglycan). In addition, we focused our
interest on the extracellular matrix compounds fibronectin,
laminin and agrin.
Fibronectin staining indicates leakage of the BBB
Fibronectin immunoreactivity (IR) in non-inflamed or
weakly inflamed vessels was restricted to the basal lamina
(Fig. 1a). However, where CD45-positive cells had trans-
migrated the vessel wall lying within the perivascular
space, fibronectin formed a meshwork surrounding the
inflammatory cells (Fig. 1b). Extended ‘‘clouds’’ of anti-
fibronectin immunoreactivity, were observed around blood
vessels in the CNS of mice with more severe EAE (score 3,
Fig. 1c). The incongruency of GFAP and fibronectin
staining supported the view that fibronectin was not pro-
duced by astrocytes, but has rather leaked from the
bloodstream across a compromised BBB into the neuropil.
Thus, by following the concept of Nag [15, 39], fibronectin
staining was used here as an indicator of the barrier char-
acteristics of the BBB rather than a vascular marker.
Tight junction proteins with exception to claudin-3
remain present in inflamed CNS microvessels
The anti-ZO-1 antibody was frequently used in this study
to identify tight junctions in endothelial cells. In all con-
ditions tested, ZO-1 staining was not decreased. Similarly,
immunoreactivities for occludin and claudin-5 were either
scarcely affected or not affected (data not shown). In
contrast, anti-claudin-3 immunoreactivity was lost from
microvessels surrounded by inflammatory cuffs confirming
our previous findings (data not shown [38]). Taken toge-
ther, the disappearance of claudin-3 immunoreactivity from
the junctions of inflamed vessels seems to be a character-
istic feature of EAE-related inflammation.
Laminin staining remains stable in endothelial
and glial basal laminae
Pan-laminin staining was the most suitable tool to recog-
nize CNS blood vessels. Capillaries as well as postcapillary
venules, with or without inflammatory cuffs, stained posi-
tive for laminin (Fig. 2b). Intensity of laminin immuno-
fluorescence staining of both the endothelial basal lamina
and the glial limiting membrane were maintained irre-
spective of the degree of inflammation or number of
extravasated CD45-positive cells suggesting that laminin
was stable and not a target of enzymatic degradation during
diapedesis. Figure 6d shows an immunogold staining of
EAE material demonstrating anti-laminin labeling of glial
and endothelial basal laminae.
b-dystroglycan is lost in astrocytes adjacent
to perivascular inflammatory cuffs
b-dystroglycan immunoreactivity in uninflamed CNS
microvessels is regularly detected in the perivascular
astroglial endfoot membranes (Fig. 2a). By immunogold
labeling using a monoclonal antibody against b-dystrogly-
can, we found gold grains exclusively in astrocytic, not
endothelial membranes of perivascular astrocytic endfoot
membranes (data not shown). Confirming the study of
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Agrawal et al. [1], we observed a loss of anti-b-dystrogly-
can staining in inflamed vessels, where CD45-positive cells
were present within the perivascular space (Fig. 2c, d). This
finding was corroborated at the electron microscopical level
by absence of b-dystroglycan-specific immunogold labeling
(data not shown). However, inflamed microvessels devoid
of CD45-positive cells were decorated with b-dystroglycan-
positive astroglial endfeet (Fig. 2c, d). Loss of b-dystro-
glycan in inflamed postcapillary venules may indicate the
role of this member of the dystrophin–dystroglycan com-
plex for the distribution of AQP4 in the astroglial
membranes.
Agrin staining is lost in endothelial, not in glial,
basal lamina
In contrast to the anti-laminin staining, the anti-agrin
immunoreactivity of the endothelial and the glial basal
laminae differed. In uninflamed postcapillary venules, both
the endothelial and the glial basal lamina were agrin-
positive (Fig. 3a). In CNS tissues from mice with a clinical
score of 1, the endothelial anti-agrin staining became
weaker, whereas the glial basal lamina maintained in
strength of staining (Fig. 3b). Finally, in CNS tissue from
animals with severe EAE (clinical score 3), the endothelial
agrin was lost and the glial basal lamina agrin was main-
tained (Fig. 3c). Thus, with increasing severity of CNS
inflammation, there is a differential loss of agrin from the
endothelial but not from the glial basal lamina within the
NVU.
GFAP- and Kir4.1-stainings indicate astroglial
hypertrophy
Anti-GFAP staining was used in order to visualize astro-
cytes in an inflammatory cuff. We found astrocytes
enormously hypertrophic around inflamed vessels (Fig. 4a).
At places, exuberant astrocytic processes were observed
between and around inflammatory cells (Fig. 4b). At the
electron microscopic level, GFAP-based intermediate fila-
ments were identified in astrocytic processes by extremely
strong immunogold labeling within the inflammatory
cuffs (data not shown). This finding confirmed that of
Fig. 1 Confocal laser scanning immunohistochemical staining of
mouse brains afflicted with EAE, using antibodies against fibronec-
tin, CD45, and GFAP (a, b), and fibronectin, CD45 and ZO-1 (c).
a 8 days after immunization, prior to clinical disease. Fibronectin
immunoreactivity is restricted to the perivascular basal lamina.
CD45-positive cells are concentrated within the perivascular space.
b 20 days after immunization, clinical score 1; CD45-positive cells
have already penetrated the glial limiting border to get access to the
CNS. The fibronectin immunoreactivity has extended beyond the
vascular border indicating that fibronectin has leaked from the blood
into the CNS. c 16 days after immunization, clinical score 3, the
degree of fibronectin leakage has increased, due to the heavier
clinical score, despite shorter time of immunization in comparison
with (b)
b
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Aoki-Yoshino [3] in human autopsies of multiple sclerosis
patients. In addition to GFAP, we also used an antibody
against the K? channel Kir4.1 in order to characterize
perivascular astrocytes within an inflammatory cuff and
found a strong anti-Kir4.1 staining in numerous astrocytic
perivascular processes (Fig. 4c, d).
AQP4 immunoreactivity seems to be redistributed
in inflammatory cuffs
The distribution of AQP4 channels in normal astrocytes is
described to be highly polarized towards astrocytic foot
processes. Accordingly, in normal brain (Fig. 5a), or in
uninflamed vessels of EAE brain (Fig. 5b), the anti-AQP4
staining was clearly restricted to glial endfeet around
microvessels. The neuropil between uninflamed vessels
was completely free of any anti-AQP4 staining. However,
if comparing EAE tissue obtained from mice without
clinical score (Fig. 5b) with EAE tissue obtained from
mice with a clinical score 1 (Fig. 5c), and EAE tissue
obtained from mice with a clinical score 3 (Fig. 5d), we
found—using strictly the identical laser parameters at the
confocal laser scanning microscope—a constant increase
of anti-AQP4-related fluorescence intensity in the areas of
perivascular inflammatory cuffs correlating to the severity
of EAE. Western blot analysis of the cerebellum and spinal
cords of differently scored EAE animals and healthy con-
trols failed to detect enhanced AQP4 protein levels (data
not shown), further supporting the notion that the enhanced
AQP4 levels observed by immunofluorescence stainings
are restricted to the inflammatory cuffs with the sur-
rounding CNS tissue being unaffected. Due to the
Fig. 2 Confocal laser scanning immunohistochemical staining of
mouse brains afflicted with EAE (b–d), using antibodies against b-
dystroglycan and laminin. d Merged image from (b) and (c), b shows
separately laminin and (c) b-dystroglycan. a Normal mouse brain
showing a restriction of b-dystroglycan (green) to the glial endfoot
membrane around the laminin-positive subendothelial basal lamina
(red). b–d 14 days after immunization, clinical score 3. Whereas the
capillaries leading to the postcapillary venule (arrows) are immuno-
reactive for both laminin and b-dystroglycan, the postcapillary venule
in the middle of the picture shows a widened perivascular space with a
specific loss of b-dystroglycan in the glial membrane
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relevance of the question, whether the enhancement of the
anti-AQP4 signal in EAE does really reflect a redistribution
of AQP4 in astrocytes of an inflammatory cuff, we decided
to perform immunogold labeling and a freeze-fracture
analysis of EAE material.
When compared with an uninflamed vessel, which
showed AQP4-specific immunogold particles predomi-
nantly at the perivascular glial endfoot membranes
(Fig. 6a), inflammatory cuffs contained astrocytes reveal-
ing immunoreactive gold labeling not only at the
perivascular membranes (Fig. 6b, c, small arrows) but also
at parenchymal membranes (Fig. 6b, c, large arrows).
Figure 6 c, d shows consecutive sections with immunogold
labeling of AQP4 (c) and laminin (d). Membranes covered
by a basal lamina were largely occupied by immunogold
particles indicating the presence of AQP4 (Fig. 6c, small
arrows). The opposing membrane as directed to the
neuropil was not covered by a basal lamina but labeled by
anti-AQP4-immunogold particles as well (Fig. 6b, c, large
arrows) indicating a redistribution of AQP4 over the
astrocytic surface. For better clarity, the situation visual-
ized in Fig. 6c, d was drawn in a schematic sketch
(Fig. 6e).
Rearrangement of astroglial membranes facing
an inflammatory cuff
The freeze-fracture analysis of inflammatory EAE cuffs was
extremely difficult due to the lack of the normal morphology
of the NVU characterized by astrocytic endfeet, pericytes
and endothelial cells. In a cuff, inflammatory cells can be
intermingled with neurons or non-astrocytic glial cells, and
the astrocytic endfeet are distant from the endothelium, and
separated by the perivascular space, which may or may not
be filled with inflammatory cells. This may lead to situations,
which could not always be accurately interpreted in the
freeze-fracture replica. Nevertheless, by investigating
numerous replicas of inflammatory cuff-containing cere-
bellar tissue, we were able to identify a massive alteration of
the architecture of astrocytic membranes. Figure 7a shows a
blood vessel surrounded by several cells (not seen in the
image). The nature of these cells could not be determined;
however, they seemed to be inflammatory cells, because in
the blood vessel a nucleated blood cell was just leaving the
Fig. 3 Confocal laser scanning immunohistochemical staining of
mouse brains afflicted with EAE (b, c), using antibodies against agrin
and ZO-1 (a), agrin and CD45 (b), and agrin, ZO-1 and CD 45 (c).
a Normal mouse brain showing clear restriction of agrin immunoreac-
tivity to the perivascular basal lamina. b 20 days after immunization,
clinical score 1. The outer (glial), but not the inner (endothelial) basal
lamina is completely intact and maintained concerning agrin content,
CD45-positive cells are restricted to the perivascular space of the
postcapillary venule. c 12 days after immunization, clinical score 3.
CD45-positive cells have penetrated the perivascular space and
invaded the CNS. The inner ring of endothelial basal lamina around
the ZO-1-positive endothelial cells is devoid of agrin, whereas the
outer ring is still intact and continuous
b
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lumen. This could be demonstrated in more detail higher
magnified in Fig. 7b which showed the opening of the
endothelial lining by the extravasating leukocyte coming in
contact with the astrocytic endfoot (double-arrow), from
which a piece of E-face (AEF in Fig. 7b) can be seen. The
cytoplasm of this astrocyte endfoot is seen as an extremely
thin layer covered by a cell the E-face of which is seen in
Fig. 7c. In our context it is important that the astrocytic P-
face irregularly exposed through gaps of this E-face varied
considerably in the content of OAPs. Two detailed views
(Fig. 7c, d) revealed the extremely different density of OAPs
in astrocytic domains not directly contacting the glial lim-
iting membrane.
The astrocytic membrane as shown in Fig. 7d, not only
showed few OAPs in the parenchymal membrane, but also
an aggregation of intramembraneous particles. Sometimes,
it seemed that the particles would form incomplete OAPs.
This finding was more clearly visible in another replica of
the same tissue, in which an astrocytic parenchymal
membrane could be shown not far away from a postcap-
illary venule (Fig. 8a, b). In this membrane, a large cluster
of particles was formed, which was reminiscent of AQP4
lattices, which were found after transfection of cells with
the cDNA of the M23 isoform of AQP4 [6].
Another replica analysis from a brain slice of an EAE
mouse (clinical score 2) with inflammatory cuffs showed,
for the first time in the literature, large lattice-like OAPs in
membranes (Fig. 9b, c) not adjacent to basal laminae but to
unidentified cells, which nevertheless were non-endothelial
and non-glial in nature (asterisk in Fig. 9a).
Fig. 4 Confocal laser scanning immunohistochemical staining of
mouse brains afflicted with EAE, using antibodies against CD 45, ZO-
1 and GFAP (a, b) and Kir4.1 (c, d), respectively. a 20 days after
immunization, clinical score 1, CD45-positive cells are concentrated
within the perivascular space. b 14 days after immunization, clinical
score 3, CD45-positive cells have already penetrated the glial limiting
border to get access to the CNS. c, d Vessels, 12 days after
immunization, clinical score 3. In (d), superficial and perivascular
endfeet positive for Kir4.1 are shown. Here, no cuffs are formed,
confirming that the alterations seen in (c) are specific for
inflammation
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Discussion
The main finding of this study is the loss of polarized
expression of AQP4 on astrocyte endfeet from astrocytes
within perivascular inflammatory cuffs during EAE. Within
the inflammatory cuff, dystroglycan selectively disappeared
from astrocytes and AQP4 redistributed from the endfeet
membranes to the parenchymal membranes of the astrocyte
body. The degree of both alterations correlated with the
amount of CNS inflammation and clinical severity of EAE.
AQP4 in EAE
AQP4 is the main water channel protein isoform in
the CNS and strictly distributed in a polarized fashion.
The astroglial endfoot membranes carry the greatest part of
the AQP4 molecules, whereas in non-endfoot membranes
AQP4 molecules occur only in low density. Under the
conditions of multiple sclerosis, the AQP4 protein is
upregulated [3, 28]; under conditions of NMO the AQP4
protein was found to be absent [28]. In order to explain this
difference between two clinically related neuroinflamma-
tory diseases, it has to be taken into account that in NMO
the autoantigen is not a myelin component but AQP4 [10].
In the present study, we found not only an apparent
increase of the anti-AQP4 immunoreactivity in EAE
(Fig. 5) but also a redistribution of AQP4 over the surface
of the astrocyte. Both phenomena, increase and redistri-
bution, do not appear to be connected in principle, because
in the a-syntrophin null mouse the redistribution of AQP4
Fig. 5 Confocal laser scanning immunohistochemical staining of
mouse brains afflicted with EAE (b–d), using antibodies against
AQP4, CD45, and ZO-1. a Normal mouse brain showing no
inflammation and a restriction of AQP4 immunoreactivity (red) to
the perivascular glial endfeet membranes. In b–d, the confocal laser
scanning parameters were strictly the same in all three images. b
8 days after immunization, without clinical score, only few CD45-
positive cells have transmigrated the blood–brain barrier. c 20 days
after immunization, clinical score 1, CD45-positive cells (red) are
restricted to the perivascular space, AQP4 immunoreactivity (green)
is eventually increased in the neuropil giving raise to the investigation
as shown in Figs. 7, 8, and 9. d 11 days after immunization, clinical
score 3. CD45-positive cells (green) have now invaded the CNS; in
this animal, AQP4 (red) is restricted to the perivascular astroglial
endfeet membranes
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was not associated with an alteration of AQP4 expression
[17]. The comparison of the a-syntrophin null mouse with
the EAE shows that the stability of the AQP4 molecule in
the endfoot membrane not only depends on the presence
of a-syntrophin, but also on the integrity of complex
molecular interactions at the glio–vascular interface, which
may be disturbed in EAE. Among the molecules, which are
essential for the integrity of the BBB in general and the
protection of the brain against leukocyte diapedesis in
particular, is dystroglycan.
Fig. 6 Electron microscopical
immunogold labeling using
antibodies against AQP4 (a–c)
and laminin (d). a Normal
mouse brain showing restriction
of AQP4-specific gold grains to
the perivascular astroglial
endfoot membrane (arrows).
b 15 days after immunization,
clinical score 2, AQP4-specific
gold grains are no more
restricted to astroglial endfeet
membranes (small arrows point
to endfoot staining, large
arrows to parenchymal
staining). c, d 15 days after
immunization, clinical score 2,
consecutive sections stained
against AQP4 (c) and laminin
(d). AQP4-specific gold grains
in (c) are no more restricted to
astroglial endfeet membranes
(small arrows point to endfoot
staining, large arrows to
parenchymal staining).
e Schematic reconstruction of
(c) and (d) for better
understanding of the topological
situation as shown in c, d. The
anti-AQP4-gold labeling of the
astroglial parenchymal
membrane indicates the
redistribution of AQP4 over
the surface of the glial cell.
A Astrocyte, M monocyte in
the perivascular space
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Dystroglycan
Cleavage of astrocytic dystroglycan by matrix metallo-
proteinases 2 and 9 (MMP-2, -9) at sites of leukocyte
diapedesis across the BBB in EAE has first been reported
by Agrawal et al. [1], and disappearance of anti-dystro-
glycan immunoreactivity has been confirmed by the
present study (Fig. 2). Dystroglycan and the DDC have
been described in the CNS, including synapses, astrocytes
and endothelial cells [5, 31, 40]. In astrocytes, actin fila-
ments of the cytoskeleton are either linked to dystrophin or
utrophin, which is also called dystrophin-related protein.
Dystrophin is connected via its amino-terminal domain to
dystroglycan, which consists of an a- and a b-subunit. Both
subunits are encoded by a single gene and are formed by
cleavage of a precursor protein into two mature proteins
that form a tight non-covalent complex [7, 35]. The
transmembrane protein b-dystroglycan anchors a-dystro-
glycan to the cell membrane and the cytoskeleton via its
linkage to the C-terminal domain of dystrophin. The brain-
selective deletion of the dystroglycan gene was described
to cause brain malformations such as disorganization of
cortical layering and aberrant migration of granule cells
[14]. On the other hand, absence of dystroglycan by means
of MMP-dependent degradation seems to be a prerequisite
for entry of inflammatory cells into the CNS parenchyma
during EAE and establishment of clinical disease [1].
Indeed, in the present study absence of any dystroglycan
immunoreactivity seemed to correlate strictly to the pres-
ence of CD45-positive inflammatory cells: after leaving the
EAE plaque, the blood vessel lining was again decorated
by anti-dystrogycan immunoreactivity.
Fig. 7 Freeze-fracture replica of a vibratome section from a mouse
cerebellum, 14 days after immunization, clinical score 2. The
presence of cuffs was shown by light microscopy. a Low magnified
overview of a vessel, filled with a leukocyte (LC). N Nucleus of the
leukocyte. The large box frames the area shown in (b) at higher
magnification. AEF E-face of an astrocytic endfoot occupied by
densely packed OAP pits (difficult to recognize at this magnification).
The double-arrow marks the direct access of the leukocyte to the sub-
endfoot space. EPF E-face of the lumenal endothelial cell membrane.
APF P-face of the astrocyte directed away from the vessel. EF E-face
of an unidentified cell directly adjacent to the astrocyte. c, d Higher
magnifications of the replica site framed with the small boxes in a. In
c, the P-face of the astrocyte (APF) contains many OAPs, whereas at
a site (d) distant from site (c), only few OAPs are present (circled)
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AQP4/OAP and agrin
Another novel observation, namely the detection of AQP4
as well as OAPs away from the astroglial endfoot mem-
brane in such an inflammatory cuff has interesting
implications. In the healthy brain tissue, AQP4 immuno-
reactivity and OAPs were restricted to the astroglial
endfoot membrane adjacent to CNS microvessels, clearly
demonstrating the polarization of astrocytes in dependence
of the presence of components of the basal lamina. Among
these components, the heparan sulfate proteoglycan agrin
has recently been identified as a candidate molecule for
inducing astrocyte polarity, because the endothelial agrin
isoform A0B0 was able to cluster OAPs in the astroglial
membrane [19]. Previous findings have shown that in
human glioblastoma (1) agrin was lost where the blood–
brain barrier tight junctions were disturbed [21], (2) AQP4
was upregulated [25] and redistributed [33], and (3) OAPs
disappeared [18]. These findings together tempted us to
speculate that under pathological conditions AQP4 can also
occur as non-OAPs (increase of AQP4 protein amount and
decrease of OAPs did not allow another conclusion) and
that agrin would be responsible to cluster AQP4 tetramers
as a supramolecular complex visible in the freeze-fracture
replica.
AQP4 exists in six different splice variants [13] known
as the AQP4 a–f isoforms. AQP4a is identical with the
previously named M1 isoform, and AQP4c is identical with
the previously named M23 isoform. M1 is 22 amino acids
longer at the N-terminus than M23 [8]. Transfection of
AQP4-M23 but not of AQP4-M1 into CHO cells induces
the formation of OAPs in the transfected cells [6]. If both
AQP4 isoforms were cotransfected, the OAPs formed in
the transfectants closely resembled those found on astro-
cytic endfeet in vivo. In parallel, the water permeability
coefficient of the M23 water channel if transfected into
LLC-PK1 cells was much greater than that of the M1 water
channel [26].
Recently, we demonstrated that the endothelial agrin
isoform A0B0 did not change the expression level of
M1 and M23, but that the neuronal agrin isoform A4B8
was able to upregulate M23 and downregulate M1, thus
increasing the M23/M1 ratio by the factor of about 6 [19].
However, this change of the ratio was not reflected by a
considerable change of the OAP density in the astrocytic
membrane. The OAP density was only changed if astro-
cytes were under the influence of the endothelial agrin
A0B0. In the agrin-deficient mouse, the amount of OAPs
was drastically decreased without change in the immuno-
histochemical stainings using antibodies against AQP4
[20]. This is additional evidence arguing that indeed agrin
is essentially responsible for the aggregation of AQP4
subunits to OAPs.
AQP4/OAP and dystroglycan in EAE
Although we could reproduce the finding of Agrawal et al.
[1] that in focal EAE inflammatory cuffs, immunostaining
for dystroglycan is lost we cannot fully confirm their pre-
vious finding that presence of agrin staining remained
unchanged. Our present study revealed a decrease of anti-
agrin-immunofluorescence staining in the endothelial, but
Fig. 8 Freeze-fracture replica of a vibratome section from a mouse
cerebellum, 14 days after immunization, clinical score 2. The
presence of cuffs was shown by light microscopy. a Low magnified
overview of a blood vessel (BV) with endothelial cells (EC). The box
frames the site which is shown in (b) at higher magnification. b Detail
of the astrocyte which is perivascular the blood vessel as shown in (a).
APF P-face of the astrocyte occupied by many intramembranous
particles few of them are OAPs (marked by small circles). The
complex labeled by the large circle is reminiscent of OAP-based
lattices known to be formed after transfection with M23-AQP4 (see
text)
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not in the glial basal lamina. It will remain to be shown
whether this is due to different pathomechanisms applying
to clinical EAE in SJL mice (this study) versus C57BL/6
mice [1]. In any case, agrin in the glial basal lamina
anchoring the astrocytic endfeet remained stable in the
inflamed vessels, whereas dystroglycan staining disap-
peared specifically in the astrocytic endfoot domains. In
freeze-fracture replicas, we found an enlarged amount of
OAPs in astrocytes, not only in vessel-associated domains,
but also in parenchymal domains apart from the contact
with vessels as well. This implied that in the presence of
agrin, but absence of dystroglycan, OAPs can be formed
but their targeting may not be restricted to the endfoot
domain.
This finding has an important consequence: in former
studies we repeatedly stressed the point that if agrin
influences the clustering of OAPs, dystroglycan should be a
member of the OAP complex, because agrin does not bind
to AQP4 directly but rather to a-dystroglycan. However,
here we observed that under conditions of CNS inflam-
mation, dystroglycan but not OAPs disappeared ([1],
present study, Fig. 2). On the contrary, the density of OAPs
in parenchymal membranes of the astrocytes seemingly
increased, and in some areas, the OAPs grew to lattices
reminiscent of those, which were induced after transfection
of M23 AQP4 [6]. This was in particular the case, where
the astrocyte was in direct contact to cells which were
though unidentified neither endothelial nor glial cells
assuming that they could be inflammatory cells. This point
has to be verified in separate in vitro studies, which are
currently designed. Taken together, we conclude that dys-
troglycan directs the correct location of the OAPs in
endfoot domains of astroglial cells, whereas agrin is
involved in the aggregation of AQP4 to OAPs.
The redistribution of OAPs in inflamed vessels under the
conditions of dystroglycan degradation should also have
functional consequences for the water flux in the inflamed
brain. It has been well known for many years that there is a
colocalization of the weakly inwardly rectifying potassium
channel Kir4.1 and AQP4 at the membrane of astrocytic
endfeet surrounding CNS microvessels [16]. Both channels
are essentially involved in the spatial buffering of the
extracellular K? concentration: neuronally (synaptically)
induced increase of extracellular [K?] is answered by K?
influx, and, osmotically driven, water influx into the glial
cell, which is followed by a distant efflux where the density
Fig. 9 Freeze-fracture replica of a vibratome section from an EAE-
cuff, 14 days after immunization, clinical score 2. b Corresponds to
the area framed in (a) at a higher magnification, c detail of the framed
area in (b). An astrocytic process is in contact with a non-endothelial
cell and non-glial cell, thus presumably an inflammatory monocytic
cell (asterisk in a). In (b), this process is shown in more detail: PF
P-face, EF E-face which contains many OAP pits (not visible at this
magnification). The area between P- and E-face corresponds to the
astrocytic cytoplasm. c High-power magnification of the P-face in (b)
showing large OAP lattices normally not seen in astrocytes in vivo
b
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of potassium and water channels is highest, namely at the
endfoot membrane. Thus, water fluxes are driven by ion
fluxes, and K?-clearance is coupled to water flux [27].
Accordingly, in the a-syntrophin-deficient mouse, in which
AQP4 is dislocalized across the glial surface, the K?-
clearance was delayed [2] indicating that K? uptake would
be facilitated, if accompanied by water flux and delayed, if
water transporters were dislocalized. In human glioblas-
toma tissue we were able to observe a redistribution of both
anti-AQP4- and anti-Kir4.1-immunoreactivities over the
surface of the glioma cells [34]. Considering inflammation
in EAE, the disturbance in OAP distribution as a result of
dystroglycan degradation could lead to a water flux, which
would increase the vasogenic edema. Vasogenic edema
rises as a consequence of blood–brain barrier disruption
(from the blood compartment), and by water influx after
K?-clearance and misdirection of water not only to the
astrocytic endfoot membranes but also to the lateral
domains associated with the interstitial space (from the
neural compartment). Further experiments are needed to
understand the molecular networks at the glio–vascular
interface, which are disorganized under the conditions of
EAE and possibly multiple sclerosis, which contribute to
edema formation.
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